Coherus Oncology
CHRS
CHRS
188 hedge funds and large institutions have $1.31B invested in Coherus Oncology in 2019 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.25% more ownership
Funds ownership: 99.43% → 103.68% (+4.3%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less capital invested
Capital invested by funds: $1.41B → $1.31B (-$96.2M)
Holders
188
Holding in Top 10
3
Calls
$8.76M
Puts
$4.67M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$15.7M | |
| 3 | +$14.9M | |
| 4 |
D.E. Shaw & Co
New York
|
+$13.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$12.7M |
Top Sellers
| 1 | -$77.2M | |
| 2 | -$41.8M | |
| 3 | -$31.2M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.61M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.31M |